论文部分内容阅读
目的 应用易善力注射液治疗慢性重型肝炎、慢性肝炎和脂肪肝 ,进一步评价其安全性和疗效。方法 本临床研究为多中心、开放试验 ,入选病人用易善力注射液 5 0 0mg(2支 )加于 5 %～ 10 %的葡萄糖溶液 2 5 0ml中静脉缓滴 ,每日 1次 ,共治疗 3～ 6周。所有病例均在治疗前及用药后 3周或 6周进行常规临床体检及进行血、尿常规、肝功能和肾功能检查 ,并记录临床症状的变化。结果 治疗 3周时 ,按照疗效判定标准 :显效 18.0 % ,有效 6 0 .5 % ,无效 2 1.5 % ,总有效率 (显效加有效 )为 78.5 %。结论 易善力注射液治疗慢性肝病疗效确切且安全可靠。
Objective To investigate the safety and efficacy of Yi Shan Li injection in the treatment of chronic severe hepatitis, chronic hepatitis and fatty liver. Methods The clinical study of multi-center, open trial, the selected patients with 50000 mg of Yishenli injection (2) added to 5% to 10% glucose solution 250ml intravenous drip once a day for a total of Treatment for 3 to 6 weeks. All cases were routine clinical examination and blood, urine, liver function and renal function tests before treatment and 3 weeks or 6 weeks after treatment, and the changes of clinical symptoms were recorded. Results 3 weeks after treatment, according to the criteria of curative effect, the effective rate was 18.0%, the effective rate was 60.5%, the ineffective rate was 2.5%. The total effective rate (effective and effective) was 78.5%. Conclusion Yishenli injection for the treatment of chronic liver disease is effective and safe.